CVS Health Corporation
CVS
$64.78
-$0.84-1.28%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 94.07B | 96.96B | 94.88B | 90.84B | 87.98B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 94.07B | 96.96B | 94.88B | 90.84B | 87.98B |
| Cost of Revenue | 80.19B | 84.81B | 82.87B | 77.85B | 75.88B |
| Gross Profit | 13.88B | 12.14B | 12.01B | 12.99B | 12.11B |
| SG&A Expenses | 10.58B | 10.25B | 10.52B | 10.24B | 10.13B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 90.78B | 95.06B | 93.39B | 88.09B | 86.01B |
| Operating Income | 3.29B | 1.90B | 1.49B | 2.75B | 1.98B |
| Income Before Tax | 2.62B | 2.13B | 105.00M | 2.34B | 1.58B |
| Income Tax Expenses | 835.00M | 503.00M | 34.00M | 569.00M | 456.00M |
| Earnings from Continuing Operations | 1.78B | 1.62B | 71.00M | 1.77B | 1.12B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.00M | 21.00M | 16.00M | 2.00M | -11.00M |
| Net Income | 1.78B | 1.64B | 87.00M | 1.77B | 1.11B |
| EBIT | 3.29B | 1.90B | 1.49B | 2.75B | 1.98B |
| EBITDA | 4.45B | 3.04B | 2.65B | 3.90B | 3.12B |
| EPS Basic | 1.41 | 1.31 | 0.07 | 1.41 | 0.88 |
| Normalized Basic EPS | 1.51 | 0.92 | 0.67 | 1.22 | 0.85 |
| EPS Diluted | 1.41 | 1.31 | 0.07 | 1.41 | 0.88 |
| Normalized Diluted EPS | 1.51 | 0.92 | 0.67 | 1.21 | 0.85 |
| Average Basic Shares Outstanding | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B |
| Average Diluted Shares Outstanding | 1.26B | 1.26B | 1.26B | 1.26B | 1.27B |
| Dividend Per Share | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 |
| Payout Ratio | 47.22% | 50.97% | 962.07% | 48.47% | 75.47% |